Loading...
Actuate Therapeutics Inc (ACTU) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators show a bearish trend, and the financial performance reveals declining net income and EPS. Additionally, there are no significant positive catalysts, news, or trading signals to support a buy decision. Holding off on investing in this stock is recommended until more favorable conditions arise.
The MACD is slightly positive at 0.0284, indicating weak bullish momentum, but the RSI at 36.133 is neutral and does not suggest a clear signal. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below the pivot level of 4.114, closer to the support level of 3.818. Overall, the technical trend is bearish.
NULL identified. No recent news, trading trends, or significant positive developments.
The stock has a bearish technical setup, declining financial performance (net income and EPS), and no recent news or trading trends to indicate a positive outlook.
In Q3 2025, revenue remained at 0 with no YoY growth. Net income dropped to -$5,407,470, down -9.44% YoY, and EPS fell to -0.25, down -19.35% YoY. Gross margin remained at 0 with no growth. Overall, the financial performance is weak.
No analyst rating or price target data is available for this stock.